KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to 0.42.

  • Novartis Ag's Equity Ratio fell 278.38% to 0.42 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.42, marking a year-over-year decrease of 278.38%. This contributed to the annual value of 0.42 for FY2025, which is 278.38% down from last year.
  • Latest data reveals that Novartis Ag reported Equity Ratio of 0.42 as of Q4 2025, which was down 278.38% from 0.01 recorded in Q1 2025.
  • In the past 5 years, Novartis Ag's Equity Ratio registered a high of 0.51 during Q4 2021, and its lowest value of 0.01 during Q1 2022.
  • Its 5-year average for Equity Ratio is 0.22, with a median of 0.01 in 2025.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 1504.25% in 2021, then plummeted by 773.7% in 2024.
  • Quarter analysis of 5 years shows Novartis Ag's Equity Ratio stood at 0.51 in 2021, then fell by 1.69% to 0.51 in 2022, then fell by 7.55% to 0.47 in 2023, then dropped by 7.74% to 0.43 in 2024, then fell by 2.78% to 0.42 in 2025.
  • Its last three reported values are 0.42 in Q4 2025, 0.01 for Q1 2025, and 0.43 during Q4 2024.